Clinical Trial Update: A Study on How CagriSema Affects Levels of Atorvastatin and Warfarin in the Blood of Participants With Excess Body Weight [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating the effect of CagriSema on blood levels of atorvastatin and warfarin in adults with obesity; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obesity

Drugs mentioned

• CagriSema (cagrilintide/semaglutide)
• Coumadin (warfarin)
• Lipitor (atorvastatin)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Obesity | Phase 1 | Status: COMPLETED